Commitment COM-226
Post-approval commitment for HC-2024-0026. Category: Pharmacovigilance. Priority: low.
Commitment ID
COM-226
Application
Authority
Health Canada
Category
Pharmacovigilance
Priority
low
Status
Open
Due Date
2025-10-15
Completed At
—
Owner
Tomoko Ikeda
Created
2023-04-08
Description
Complete Phase IV post-marketing observational study (n=500)
Evidence (0)
No evidence documents attached. Upload evidence to mark this commitment as complete.